Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...
For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...
City of Hope was the first U.S. institution to offer PIPAC in a clinical trial, and has hosted the first and second U.S. PIPAC training workshops. The City of Hope-led multicenter phase 1 trial ...
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
This is the third indication under clinical development for soquelitinib, which is also in a registrational Phase 3 trial for peripheral T cell lymphoma (PTCL) and a Phase 1 trial for atopic ...
CERo Therapeutics (CERO) announces the execution of an agreement with contract research organization CellCarta to manage translational assays ...
The eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial is evaluating the efficacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results